Sign In
Buy ESTA
$92.54
-0.94 (-1.01%)
At Close: Jul 31, 2026
Establishment Labs Appoints Peter Caldini as Chief Executive Officer
04:00pm, Wednesday, 07'th May 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Earnings Preview: Establishment Labs Holdings Inc. (ESTA) Q1 Earnings Expected to Decline
11:06am, Wednesday, 30'th Apr 2025
Establishment Labs (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Establishment Labs to Announce First Quarter 2025 Financial Results on May 7
08:00am, Thursday, 24'th Apr 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12
09:00am, Thursday, 10'th Apr 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025
08:00am, Thursday, 20'th Mar 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants®
12:00pm, Thursday, 06'th Mar 2025
The campaign is the first-of-its-kind partnership and follows the US FDA approval of Motiva Implants® NEW YORK , March 6, 2025 /PRNewswire/ -- Establishment Labs® Holdings Inc. (NASDAQ: ESTA), a
Establishment Labs Holdings Inc. (ESTA) Q4 2024 Earnings Call Transcript
08:56pm, Wednesday, 26'th Feb 2025
Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Raj Denhoy - CFO Juan Chacón-Quirós - CEO Peter Caldini - President
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Lags Revenue Estimates
06:11pm, Wednesday, 26'th Feb 2025
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.98 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $0.79 per share a year ago.
Establishment Labs Reports Fourth Quarter and Full Year 2024 Financial Results and Reaffirms 2025 Guidance
04:00pm, Wednesday, 26'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs to Present at Citi's 2025 Unplugged Medtech and Life Sciences Access Day
08:00am, Friday, 21'st Feb 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Launches Preservé™
08:00am, Tuesday, 18'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness in breast aesthetics and reconstructi
Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26
08:00am, Friday, 14'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference
08:00am, Tuesday, 07'th Jan 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call Transcript
08:55am, Saturday, 09'th Nov 2024
Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Rajbir Denhoy - Chief Financial Officer Juan Jose - CEO and Founder Co
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Misses Revenue Estimates
06:21pm, Thursday, 07'th Nov 2024
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $1.12 per share a year ago.
